藥品契約製造的全球市場規模、佔有率和成長分析：按服務、按最終用戶、按地區 - 行業預測（2024-2031）

2022年全球藥品契約製造市場規模預計為190億美元，預測期內（2024-2031年）複合年成長率為5.9%，從2023年的201.2億美元增至2031年的3180億美元，預計將成長至2000萬美元。

由於幾個關鍵促進因素，全球藥品契約製造市場正在強勁成長。在這一領域，將藥品生產外包給專業的第三方製造商可以使製藥公司專注於其核心職能。關鍵的成長要素包括對具有成本效益的製造的需求不斷增加、向靈活製造的轉變以及外包非核心業務的趨勢不斷成長。此外，藥物開發的複雜性和對專業製造能力的需求正在推動市場擴張。競爭格局包括許多提供各種契約製造服務的大公司。由於先進技術的採用和藥品供應鏈的預期全球化，預計未來幾年市場將持續成長。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析和影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 案例研究

藥品契約製造市場規模：依服務分類，複合年成長率（2024-2031）

• 藥品製造服務
• 藥物開發服務
• 生技藥品製造服務
• 包裝和標籤服務
• 灌裝和整理服務
• 其他服務

藥品契約製造市場規模：依最終用戶分類，複合年成長率（2024-2031）

• 大型製藥公司
• 中小型製藥公司
• 學名藥公司
• 其他最終用戶

藥品契約製造市場規模：按地區，複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Thermo fisher scientific inc.
• Lonza
• Catalent, inc.
• Wuxi apptec
• Sharp Services, LLC
• Samsung biologics
• Boehringer ingelheim international gmbh
• Evonik industries ag
• Fujifilm holdings corporation
• Abbvie inc.
• Siegfried holding ag
• Merck kgaa
• Almac group
• Charles river laboratories
• Asymchem inc.
• Vetter pharma
• Alcami corporation
• Piramal pharma solutions
• Syngene international limited
• Cambrex corporation

結論和建議

Global Pharmaceutical Contract Manufacturing Market size was valued at USD 19 billion in 2022 and is poised to grow from USD 20.12 billion in 2023 to USD 31.82 billion by 2031, growing at a CAGR of 5.9% in the forecast period (2024-2031).

The Global Pharmaceutical Contract Manufacturing market is experiencing robust growth, fueled by several key drivers. This sector involves outsourcing drug production to specialized third-party manufacturers, enabling pharmaceutical companies to concentrate on their core functions. Key growth factors include a rising demand for cost-effective production, a shift towards flexible manufacturing, and an increasing tendency to outsource non-core activities. Furthermore, the complexity of drug development and the necessity for specialized manufacturing capabilities are propelling market expansion. The competitive landscape features numerous major players providing diverse contract manufacturing services. With the anticipated adoption of advanced technologies and the globalization of pharmaceutical supply chains, the market is poised for sustained growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Contract Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Contract Manufacturing Market Segmental Analysis

Global Pharmaceutical Contract Manufacturing Market is segmented by Services, End User and Region. Based on Services, the market is segmented into Pharmaceutical manufacturing services, Drug development services, Biologics manufacturing services, Packaging & labelling services, Fill-finish services, and Other services. Based on End User, the market is segmented into Big pharmaceutical companies, Small & medium-sized pharmaceutical companies, Generic pharmaceutical companies, and Other end users. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Contract Manufacturing Market

A key driver of the Global Pharmaceutical Contract Manufacturing market is the rising demand for cost-effective and efficient manufacturing solutions. Pharmaceutical companies are increasingly turning to contract manufacturing organizations (CMOs) to outsource their production processes, aiming to lower operational expenses and concentrate on their core strengths. This strategic shift not only enables them to tap into specialized expertise and advanced technologies but also facilitates streamlined operations, improved resource management, and faster time-to-market for their products. As a result, this trend significantly enhances their competitiveness in the pharmaceutical landscape, driving growth within the contract manufacturing sector.

Restraints in the Global Pharmaceutical Contract Manufacturing Market

One significant restraint impacting the Global Pharmaceutical Contract Manufacturing market is the stringent regulatory requirements and quality standards that govern the industry. Contract Manufacturing Organizations (CMOs) are obligated to comply with a variety of regulatory frameworks, including Good Manufacturing Practices (GMP), which are critical for ensuring the safety, efficacy, and quality of pharmaceutical products. Adhering to these regulations often demands substantial investments in infrastructure, advanced equipment, and skilled personnel, which can be both time-consuming and costly. Non-compliance poses serious risks, including regulatory penalties, damage to reputation, and potential product recalls, creating considerable challenges for CMOs operating in this market.

Market Trends of the Global Pharmaceutical Contract Manufacturing Market

The global pharmaceutical contract manufacturing market is witnessing a robust trend of increasing outsourcing by pharmaceutical companies, driven by significant factors such as cost efficiency, enhanced production flexibility, and the need for specialized skills. As companies seek to streamline operations and allocate resources more effectively, reliance on contract manufacturing organizations (CMOs) has surged, enabling firms to concentrate on their core areas like research and development. This shift not only facilitates scalability but also accelerates time-to-market for new drugs, fostering innovation within the industry. As a result, CMOs are becoming critical partners in navigating the complexities of pharmaceutical production.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Pharmaceutical Contract Manufacturing Market Size by Services & CAGR (2024-2031)

• Pharmaceutical manufacturing services
• Drug development services
• Biologics manufacturing services
• Packaging & labelling services
• Fill-finish services
• Other services

Global Pharmaceutical Contract Manufacturing Market Size by End User & CAGR (2024-2031)

• Big pharmaceutical companies
• Small & medium-sized pharmaceutical companies
• Generic pharmaceutical companies
• Other end users

Global Pharmaceutical Contract Manufacturing Market Size by Region & CAGR (2024-2031)

• North America (Services, End User)
  • US
  • Canada
• Europe (Services, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Services, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Services, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Services, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo fisher scientific inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi apptec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sharp Services, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung biologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer ingelheim international gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik industries ag
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm holdings corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbvie inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siegfried holding ag
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck kgaa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Almac group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles river laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asymchem inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetter pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcami corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal pharma solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syngene international limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambrex corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation